#California’s success in removing friction from its #WorkersCompensation system hinges on all of the state’s stakeholders committing to work from the same standards and speaking the same language. Anything short of this type of cooperation is both counter-productive and an affront toward the collective effort to produce #ImprovedHealthOutcomes for California’s #InjuredWorkers.
Evidence-Based Medicine (EBM)
La inspiración lleva a la gente a hacer cosas increíbles, a veces cosas atípicas. En raras ocasiones, la inspiración mueve a la gente en su núcleo y activa el comportamiento y la creencia, que no es característico para ellos. Cada… Read More ›
The challenges experienced in the care and claim continuum are plentiful and very difficult to navigate. Providers, insurers, employers, and employees deserve content measured and deemed trustworthy according to non-bias standards to guide injured workers to recovery.
With the deep knowledge base and hands on experience of how quickly a workers’ compensation claim can go into free fall toward catastrophic health and recovery outcomes for the injured worker, why aren’t more “thought-leaders” challenging the status quo to identify inadvertent, or in some cases intended, consequences in their respective areas of expertise? Let me know your thoughts on “Why Standards Matter”.
As Louisiana HB 592 moves through legislature, Texas’ workers’ compensation system is again the center of national discussion. Texas Commissioner Ryan Brennan doubled down on advocacy for other states to adopt the Texas-model formulary proclaiming it “a model for the nation” and “the inspiration for many other states’ proposed formularies” citing improvements in return-to-work, medical costs and access to care. Surely, a system as unique as Texas relies on more than a binary list of drugs to accomplish the outcomes documented in its 2016 biennial report. Here is “The Truth Regarding Outcomes in Texas and the Guideline Never Discussed”. Due to reference of the Texas Labor Code, I welcome feedback specifically from the legal community on this piece.
The debate in Louisiana on a drug formulary continues. While HB 592 is being sent to House floor for a vote early next week, HB 529 remains in waiting. Here are my thoughts on why the Texas-model may not produce the expected results in Louisiana.
Is the Agency for Healthcare Research and Quality’s National Guideline Clearinghouse still relevant? Read my latest write-up on this very important subject published in the Louisiana Comp Blog.
Major Overhaul Planned for MTUS The California Department of Industrial Relations Division of Workers’ Compensation (DIR DWC) continues to demonstrate its commitment to improving the quality of medical care available to ill or injured workers in the state by announcing that all MTUS… Read More ›